BioHorizons Adds Prolifica Allogeneic Growth Factor to Biomaterials Portfolio - Takeaways - MDSpire

BioHorizons Adds Prolifica Allogeneic Growth Factor to Biomaterials Portfolio

New option uses biphasic protein release to support bone healing and tissue regeneration.

Share

1

BioHorizons has launched Prolifica™ allogeneic growth factor for bone healing and tissue regeneration.
2

Prolifica contains a blend of allogeneic growth factors and preserves a biphasic release of proteins.
3

The product supports the initiation of the healing cascade with an initial release of proteins.
4

Prolifica retains a minimum of 16 proteins related to cell growth, division, and tissue regeneration.
5

The product can be used in standalone bone grafting or in combination with autologous or allograft bone.